These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9274899)

  • 1. Insulin resistance implications for type II diabetes mellitus and coronary heart disease.
    Haffner SM; Miettinen H
    Am J Med; 1997 Aug; 103(2):152-62. PubMed ID: 9274899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prediabetic problem: development of non-insulin-dependent diabetes mellitus and related abnormalities.
    Haffner SM
    J Diabetes Complications; 1997; 11(2):69-76. PubMed ID: 9101390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenic role of hyperinsulinism in macroangiopathy. Epidemiological data].
    Valensi P
    Presse Med; 1992 Sep; 21(28):1307-11. PubMed ID: 1438099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?
    Haffner SM; Stern MP; Hazuda HP; Mitchell BD; Patterson JK
    JAMA; 1990 Jun; 263(21):2893-8. PubMed ID: 2338751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of insulin resistance and its relation to coronary artery disease.
    Haffner SM
    Am J Cardiol; 1999 Jul; 84(1A):11J-14J. PubMed ID: 10418852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of insulin resistance and hyperinsulinemia in coronary heart disease.
    Reaven GM
    Metabolism; 1992 May; 41(5 Suppl 1):16-9. PubMed ID: 1574008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors and the prediabetic syndrome.
    Haffner SM
    Ann Med; 1996 Aug; 28(4):363-70. PubMed ID: 8862692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Westernisation, insulin resistance and diabetes in Australian aborigines.
    O'Dea K
    Med J Aust; 1991 Aug; 155(4):258-64. PubMed ID: 1875844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and coronary heart disease in nondiabetic individuals.
    Reaven G
    Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):1754-9. PubMed ID: 22815340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type II diabetes and syndrome X. Pathogenesis and glycemic management.
    Karam JH
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):329-50. PubMed ID: 1612069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperinsulinism and dyslipidemias as coronary heart disease risk factors in NIDDM.
    Taskinen MR
    Adv Exp Med Biol; 1993; 334():295-301. PubMed ID: 8249693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin resistance and cardiovascular complications].
    Janka HU
    Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between insulin resistance and coronary heart disease in diabetes mellitus and the general population: a critical appraisal.
    Elliott TG; Viberti G
    Baillieres Clin Endocrinol Metab; 1993 Oct; 7(4):1079-103. PubMed ID: 8304914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapeutic agents for the treatment of NIDDM.
    Kuehnle HF
    Exp Clin Endocrinol Diabetes; 1996; 104(2):93-101. PubMed ID: 8740931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperinsulinemia--how innocent a bystander?
    Zimmet PZ
    Diabetes Care; 1993 Dec; 16 Suppl 3():56-70. PubMed ID: 8299479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of coronary heart disease in type 2 diabetes.
    Mykkänen L
    Int J Clin Pract Suppl; 2000 Oct; (113):40-5. PubMed ID: 11965831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes and other coronary heart disease risk equivalents.
    James RW
    Curr Opin Lipidol; 2001 Aug; 12(4):425-31. PubMed ID: 11507328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Deidesheimer meeting: significance of classical and new risk factors in non-insulin-dependent diabetes mellitus.
    Yudkin JS
    J Diabetes Complications; 1997; 11(2):100-3. PubMed ID: 9101395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.